Cerulea Clinical Trials

If you know someone interested in clinical research, the Cerulea website features Frequently Asked Questions, a step-by-step journey through a typical clinical trial, and much more to help people understand what being in a clinical trial is like and the impact they can have. Take a look through the resources on the Cerulea website: https://lnkd.in/gJX9EJFn

Have you seen our new website? Our website has information for healthcare practitioners about the trials we are currently running, a guide on what participants can expect when participating in a trial, and much more about how to work with us. Have a look and explore the information available. 👉 https://lnkd.in/g_3xbX2B

In celebration of NAIDOC Week, our team met yesterday on the lands of the Wurundjeri Woi-wurrung peoples for a special guest presentation from Abe Ropitini from the Victorian Aboriginal Community Controlled Health Organisation (VACCHO). Abe shared stories of history and culture, and discussed the challenges First Nations peoples face in accessing healthcare and the importance of breaking down cultural barriers in moving forward together. Most importantly, Abe gave us a welcome reminder that the work we do every day could have a huge impact. “You have a real opportunity to be at the interface of contributing to reconciliation in a really instrumental and substantial way,” he said. “We are hopeful the work you do will lead to breakthroughs that result in more effective treatments, more effective screening, and ultimately, better outcomes for communities.” A big thank you to Abe Ropitini for his time. Abe is a proud Māori man of Ngāti Kahungunu and Ngāti Maniapoto iwi, with ancestral links to Palawa Country, Tasmania – and the Executive Director for Population Health at VACCHO. Pictured: Head of Human Resources Ari Siggins, Abe Ropitini and CERA Consumer Involvement and Advocacy Lead Kelly Schulz are standing together and smiling directly at the camera. They are standing in front of a large, sectioned window, with The Royal Victorian Eye and Ear Hospital (partially obscured) and Melbourne skyline in the background with a bright grey sky. #NAIDOC2024 #NAIDOCWeek

Proud to be part of the new Melbourne Centre for Clinical Trials - a centre for clinical research excellence to elevate Melbourne’s profile as a leader in healthcare innovation and clinical trials. We’re excited by the opportunities for collaboration with consortium partners to drive the global impact of our city’s biomedical precinct. #clinicaltrials #ophthalmology #innovation

The digital edition of the CERA Annual Review is now online. This year's review is titled People in Focus and celebrates everyone who helps deliver innovative vision research that has real-life impact, from our scientists and supporters to our research partners and people living with vision loss and blindness. Highlights include: 👏 A $10 million investment from Breakthrough Victoria to launch Cerulea Clinical Trials 👏 The launch of our Gender Action Plan 👏 Two National Health and Medical Research Council (NHMRC) Ideas Grants 👏 Our Retinal Gene Therapy Unit becoming the first Australian site for Uni-Rare – a global registry to improve understanding of inherited retinal diseases and boost potential therapies 👏 An international collaboration led by our Visual Neurovascular Unit aiming to repair blood vessel and optic nerve damage in glaucoma. And many more. The full edition is on the CERA website, where you can also download a PDF of the print edition. https://lnkd.in/gNPV-zE6

It was our pleasure to welcome the team from Roche Australia today to Cerulea to share our capabilities and work towards bringing emerging treatments to more people through clinical research.

Thanks to everyone who visited the Cerulea stand at the Centre for Eye Research Australia (CERA) Vision Expo to meet the team and hear how we're delivering the best clinical trial experience for participants, clinicians and sponsors. It's exciting to be a part of the vibrant and thriving Melbourne biomedical community and have so many people share our vision of bringing the latest trials to more people.

Orthoptists are often the first health professionals you see at an eye hospital or clinic. They’re also playing a critical role in running studies on new treatments for eye disease, and ensuring the volunteer participants making these studies possible have the best possible experience. “It’s like we’re making a difference on two levels: being part of cutting-edge therapies that could potentially restore vision and building very personal connections with participants who are often living with low vision,” says Cerulea Clinical Trials CEO Michelle Gallaher. 👁️ On #WorldOrthopticDay, we’re celebrating and raising awareness of orthoptists' contributions to every part of healthcare and research. 🎉

Are you passionate about making a real difference in eye health? Do you have lived experience of eye disease or vision loss, or care for someone who does? We’re looking for independent members to join our Consumer Advisory Group (CAG). As a member of the CAG, you’ll play a crucial role in shaping research and policy development with your unique insights and experiences. You'll have the opportunity to advocate for the needs of those with eye disease and vision loss, collaborate with researchers and experts, and ensure our work remains inclusive and impactful. Join us in our mission to eliminate the major eye diseases that cause vision loss and blindness and to reduce their impact on people’s lives. Apply today! 📅 Deadline: 14 June 2024 For more details and to apply, visit our website https://lnkd.in/gPfg53di #CERA #ConsumerAdvisoryGroup #VisionLoss #EyeHealth #Research #Inclusion #Diversity

Thanks to Warwick Shaw, Marija McGeachie, Oliver Bonaccorso and Sarah P. from The Janssen Pharmaceutical Companies of Johnson & Johnson for coming on a tour of Cerulea’s new clinical trial space today! We’re excited to share our facilities and the prospect of helping bring some many of the exciting new treatments on the way to more people.